GSA Capital Partners LLP lowered its position in shares of Colgate-Palmolive (NYSE:CL) by 38.3% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 14,603 shares of the company’s stock after selling 9,082 shares during the period. GSA Capital Partners LLP’s holdings in Colgate-Palmolive were worth $1,064,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in the business. Blue Chip Partners Inc. raised its position in shares of Colgate-Palmolive by 0.4% in the 2nd quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock worth $134,000 after purchasing an additional 8 shares during the last quarter. AlphaMark Advisors LLC raised its position in shares of Colgate-Palmolive by 1.5% in the 2nd quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock worth $126,000 after purchasing an additional 25 shares during the last quarter. Weatherstone Capital Management raised its position in shares of Colgate-Palmolive by 0.7% in the 2nd quarter. Weatherstone Capital Management now owns 4,069 shares of the company’s stock worth $302,000 after purchasing an additional 28 shares during the last quarter. Dorsey & Whitney Trust CO LLC raised its position in shares of Colgate-Palmolive by 0.6% in the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 5,642 shares of the company’s stock worth $419,000 after purchasing an additional 34 shares during the last quarter. Finally, Jackson Grant Investment Advisers Inc. raised its position in shares of Colgate-Palmolive by 0.5% in the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 7,028 shares of the company’s stock worth $521,000 after purchasing an additional 35 shares during the last quarter. 72.85% of the stock is owned by institutional investors and hedge funds.
CL has been the subject of several recent analyst reports. Citigroup lowered their price target on Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a research report on Thursday, November 2nd. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price target for the company in a research report on Monday, October 23rd. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Saturday, November 25th. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target for the company in a research report on Tuesday, December 19th. Finally, SunTrust Banks raised Colgate-Palmolive from a “hold” rating to a “buy” rating and lifted their price target for the stock from $65.00 to $85.00 in a research report on Wednesday, October 11th. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $76.45.
Colgate-Palmolive (NYSE CL) opened at $77.50 on Monday. Colgate-Palmolive has a 52-week low of $63.43 and a 52-week high of $77.91. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. The firm has a market capitalization of $68,050.00, a PE ratio of 29.92, a price-to-earnings-growth ratio of 3.24 and a beta of 0.81.
Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The business had revenue of $3.97 billion during the quarter, compared to analyst estimates of $3.94 billion. During the same quarter in the previous year, the firm earned $0.73 EPS. Colgate-Palmolive’s revenue was up 2.8% on a year-over-year basis. equities analysts forecast that Colgate-Palmolive will post 2.87 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio (DPR) is 61.78%.
ILLEGAL ACTIVITY NOTICE: “GSA Capital Partners LLP Sells 9,082 Shares of Colgate-Palmolive (CL)” was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this news story on another domain, it was stolen and republished in violation of U.S. & international trademark & copyright law. The original version of this news story can be read at https://sportsperspectives.com/2018/01/22/gsa-capital-partners-llp-sells-9082-shares-of-colgate-palmolive-cl.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.